KING PHARMACEUTICALS (KG) Profit Margin (2024 - 2026)
KING PHARMACEUTICALS (KG) profit margin from Jun 30, 2024 to Mar 31, 2026. The current KING PHARMACEUTICALS (KG) profit margin is -72.91%. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Profit Margin
Quarterly Profit Margin
Annual Profit Margin change of KING PHARMACEUTICALS (KG)
| Year | Profit Margin | Change |
|---|---|---|
| 2025 | 137.24% | -509.59% |
| 2024 | -33.51% | N/A |
Comparison KING PHARMACEUTICALS (KG) profit margin with competitors
KING PHARMACEUTICALS (KG) profit margin is -72.91%.
| Ticker | Name | Profit Margin | Upside |
|---|---|---|---|
| HG | Hamilton Insurance Group Ltd - Class B | 28.60% | -139.22% |
| GLRE | Greenlight Capital Re Ltd - Class A | 18.85% | -125.85% |
| EG | Everest Group Ltd | 16.05% | -122.01% |
| RNR | RenaissanceRe Holdings Ltd | 13.37% | -118.34% |
| SPNT | SiriusPoint Ltd | 13.19% | -118.09% |
| RGA | Reinsurance Group Of America Inc | 5.08% | -106.97% |
| OXBR | Oxbridge Re Holdings Ltd | 3.53% | -104.84% |